Advanced search
1 file | 636.60 KB

Non-allergic rhinitis : position paper of the European Academy of Allergy and Clinical Immunology

(2017) ALLERGY. 72(11). p.1657-1665
Author
Organization
Abstract
This EAACI position paper aims at providing a state-of-the-art overview on nonallergic rhinitis (NAR). A significant number of patients suffering from persistent rhinitis are defined as nonallergic noninfectious rhinitis (NANIR) patients, often denominated in short as having NAR. NAR is defined as a symptomatic inflammation of the nasal mucosa with the presence of a minimum of two nasal symptoms such as nasal obstruction, rhinorrhea, sneezing, and/or itchy nose, without clinical evidence of endonasal infection and without systemic signs of sensitization to inhalant allergens. Symptoms of NAR may have a wide range of severity and be either continuously present and/or induced by exposure to unspecific triggers, also called nasal hyperresponsiveness (NHR). NHR represents a clinical feature of both AR and NAR patients. NAR involves different subgroups: drug-induced rhinitis, (nonallergic) occupational rhinitis, hormonal rhinitis (including pregnancy rhinitis), gustatory rhinitis, senile rhinitis, and idiopathic rhinitis (IR). NAR should be distinguished from those rhinitis patients with an allergic reaction confined to the nasal mucosa, also called entopy or local allergic rhinitis (LAR). We here provide an overview of the current consensus on phenotypes of NAR, recommendations for diagnosis, a treatment algorithm, and defining the unmet needs in this neglected area of research.
Keywords
classification, nonallergic rhinitis, rhinitis, treatment, NONINFECTIOUS PERENNIAL RHINITIS, EXACERBATED RESPIRATORY-DISEASE, REDUCES NASAL HYPERREACTIVITY, COLD DRY AIR, VASOMOTOR RHINITIS, IDIOPATHIC RHINITIS, DOUBLE-BLIND, ASPIRIN DESENSITIZATION, CHRONIC RHINOSINUSITIS, INTRANASAL CAPSAICIN

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 636.60 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Hellings, PW, L Klimek, C Cingi, I Agache, C Akdis, Claus Bachert, J Bousquet, et al. 2017. “Non-allergic Rhinitis : Position Paper of the European Academy of Allergy and Clinical Immunology.” Allergy 72 (11): 1657–1665.
APA
Hellings, P., Klimek, L., Cingi, C., Agache, I., Akdis, C., Bachert, C., Bousquet, J., et al. (2017). Non-allergic rhinitis : position paper of the European Academy of Allergy and Clinical Immunology. ALLERGY, 72(11), 1657–1665.
Vancouver
1.
Hellings P, Klimek L, Cingi C, Agache I, Akdis C, Bachert C, et al. Non-allergic rhinitis : position paper of the European Academy of Allergy and Clinical Immunology. ALLERGY. 2017;72(11):1657–65.
MLA
Hellings, PW, L Klimek, C Cingi, et al. “Non-allergic Rhinitis : Position Paper of the European Academy of Allergy and Clinical Immunology.” ALLERGY 72.11 (2017): 1657–1665. Print.
@article{8539030,
  abstract     = {This EAACI position paper aims at providing a state-of-the-art overview on nonallergic rhinitis (NAR). A significant number of patients suffering from persistent rhinitis are defined as nonallergic noninfectious rhinitis (NANIR) patients, often denominated in short as having NAR. NAR is defined as a symptomatic inflammation of the nasal mucosa with the presence of a minimum of two nasal symptoms such as nasal obstruction, rhinorrhea, sneezing, and/or itchy nose, without clinical evidence of endonasal infection and without systemic signs of sensitization to inhalant allergens. Symptoms of NAR may have a wide range of severity and be either continuously present and/or induced by exposure to unspecific triggers, also called nasal hyperresponsiveness (NHR). NHR represents a clinical feature of both AR and NAR patients. NAR involves different subgroups: drug-induced rhinitis, (nonallergic) occupational rhinitis, hormonal rhinitis (including pregnancy rhinitis), gustatory rhinitis, senile rhinitis, and idiopathic rhinitis (IR). NAR should be distinguished from those rhinitis patients with an allergic reaction confined to the nasal mucosa, also called entopy or local allergic rhinitis (LAR). We here provide an overview of the current consensus on phenotypes of NAR, recommendations for diagnosis, a treatment algorithm, and defining the unmet needs in this neglected area of research.},
  author       = {Hellings, PW and Klimek, L and Cingi, C and Agache, I and Akdis, C and Bachert, Claus and Bousquet, J and Demoly, P and Gevaert, Philippe and Hox, V and Hupin, C and Kalogjera, L and Manole, F and M{\"o}sges, R and Mullol, J and Muluk, NB and Muraro, A and Papadopoulos, N and Pawankar, R and Rondon, C and Rundenko, M and Seys, SF and Toskala, E and Van Gerven, L and Zhang, L and Zhang, Nan and Fokkens, WJ},
  issn         = {0105-4538},
  journal      = {ALLERGY},
  language     = {eng},
  number       = {11},
  pages        = {1657--1665},
  title        = {Non-allergic rhinitis : position paper of the European Academy of Allergy and Clinical Immunology},
  url          = {http://dx.doi.org/10.1111/all.13200},
  volume       = {72},
  year         = {2017},
}

Altmetric
View in Altmetric
Web of Science
Times cited: